Riber S.A (ALRIB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Riber S.A (ALRIB) has a cash flow conversion efficiency ratio of -0.100x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.11 Million ≈ $-2.46 Million USD) by net assets (€21.03 Million ≈ $24.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ALRIB equity financing ratio to measure how much of total assets are equity-financed.
Riber S.A - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Riber S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Riber S.A (ALRIB) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Riber S.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Riber S.A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alterity Therapeutics Ltd
AU:ATH
|
-0.196x |
|
Crosswood
PA:CROS
|
-0.020x |
|
Nordhealth AS
OL:NORDH
|
-0.008x |
|
SynAct Pharma AB
ST:SYNACT
|
-0.170x |
|
Caravel Minerals Ltd
AU:CVV
|
-0.375x |
|
DIO Corporation
KQ:039840
|
0.015x |
|
Daewon Pharm
KO:003220
|
0.111x |
|
GR Silver Mining Ltd
V:GRSL
|
-0.097x |
Annual Cash Flow Conversion Efficiency for Riber S.A (2005–2024)
The table below shows the annual cash flow conversion efficiency of Riber S.A from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see ALRIB stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €23.58 Million ≈ $27.57 Million |
€4.99 Million ≈ $5.83 Million |
0.211x | -43.81% |
| 2023-12-31 | €21.20 Million ≈ $24.79 Million |
€7.98 Million ≈ $9.33 Million |
0.376x | +43.04% |
| 2022-12-31 | €18.76 Million ≈ $21.93 Million |
€4.93 Million ≈ $5.77 Million |
0.263x | +203.57% |
| 2021-12-31 | €19.80 Million ≈ $23.14 Million |
€1.72 Million ≈ $2.01 Million |
0.087x | +143.74% |
| 2020-12-31 | €19.02 Million ≈ $22.23 Million |
€-3.77 Million ≈ $-4.40 Million |
-0.198x | -158.98% |
| 2019-12-31 | €19.19 Million ≈ $22.44 Million |
€6.45 Million ≈ $7.54 Million |
0.336x | +329.33% |
| 2018-12-31 | €19.15 Million ≈ $22.39 Million |
€-2.81 Million ≈ $-3.28 Million |
-0.146x | -143.92% |
| 2017-12-31 | €19.77 Million ≈ $23.11 Million |
€6.59 Million ≈ $7.71 Million |
0.333x | +258337.78% |
| 2016-12-31 | €15.49 Million ≈ $18.11 Million |
€-2.00K ≈ $-2.34K |
0.000x | +99.87% |
| 2015-12-31 | €15.25 Million ≈ $17.83 Million |
€-1.56 Million ≈ $-1.82 Million |
-0.102x | -299.55% |
| 2014-12-31 | €21.54 Million ≈ $25.19 Million |
€1.10 Million ≈ $1.29 Million |
0.051x | +769.21% |
| 2013-12-31 | €25.51 Million ≈ $29.83 Million |
€-195.00K ≈ $-227.98K |
-0.008x | +93.17% |
| 2012-12-31 | €26.02 Million ≈ $30.42 Million |
€-2.91 Million ≈ $-3.41 Million |
-0.112x | -182.28% |
| 2011-12-31 | €25.70 Million ≈ $30.04 Million |
€3.50 Million ≈ $4.09 Million |
0.136x | -46.77% |
| 2010-12-31 | €22.82 Million ≈ $26.68 Million |
€5.83 Million ≈ $6.82 Million |
0.256x | +55.13% |
| 2009-12-31 | €21.67 Million ≈ $25.33 Million |
€3.57 Million ≈ $4.17 Million |
0.165x | +23.89% |
| 2008-12-31 | €21.51 Million ≈ $25.15 Million |
€2.86 Million ≈ $3.34 Million |
0.133x | +155.23% |
| 2007-12-31 | €22.38 Million ≈ $26.16 Million |
€-5.39 Million ≈ $-6.30 Million |
-0.241x | -99.14% |
| 2006-12-31 | €32.73 Million ≈ $38.26 Million |
€-3.96 Million ≈ $-4.63 Million |
-0.121x | -202.71% |
| 2005-12-31 | €22.16 Million ≈ $25.91 Million |
€2.61 Million ≈ $3.05 Million |
0.118x | -- |
About Riber S.A
Riber S.A. provides molecular beam epitaxy (MBE) products and related services for the compound semiconductor research and industrial field. The company offers MBE systems, such as research and pilot production systems, real-time curvature measurement products, and laser passivation tools; and MBE sources, including effusion cells, gas and valved sources, resistive cells, and valved cracker sourc… Read more